指南与共识心力衰竭与心肌病

围产期心力衰竭:美国心脏协会科学声明

Heart Failure Occurring in the Perinatal Period: A Scientific Statement From the American Heart Association.
指南 / 共识 · Circulation · 2026-06-24

该科学声明聚焦妊娠期及产后由各类心肌病引起的射血分数降低和轻度降低的心力衰竭。针对围产期症状与生理变化重叠导致的识别困难,声明阐述诊断挑战并总结现有治疗标准。声明强调需统一疾病定义、完善筛查工具并促进孕产妇健康公平。

要点

  • 围产期呼吸困难、乏力、下肢水肿等症状常见,增加了心力衰竭识别难度。
  • 诊断延迟会导致不良孕产妇结局,应推进早期识别和及时启动适宜治疗。
  • 声明强调标准化疾病定义、有效筛查工具和孕产妇健康公平干预的必要性。

核心结论

  • 为改善孕产妇中既往存在和新发心力衰竭的管理,必须统一疾病定义、明确治疗方案、实施有效筛查工具并推动母婴健康公平。

研究设计与样本

  • 本文为美国心脏协会发布的科学声明,聚焦妊娠期及产后射血分数降低和轻度降低的心力衰竭。
  • 声明针对产科患者心力衰竭识别挑战、既有治疗标准及潜在研究方向进行阐述。

主要发现

  • 围产期心力衰竭的定义和管理仍不明确,妊娠期及产后心力衰竭或左室收缩功能不全的真实发病率与患病率未知。
  • 美国普通成人中曾报告患病率高达1%至2%。
  • 妊娠或产后状态中,呼吸困难、运动不耐受、疲劳和下肢水肿等影响躯体功能的症状常见。
  • 围产期心力衰竭识别和诊断延迟会导致不良孕产妇结局。

关键数值与推荐

  • 美国普通成人中报告的心力衰竭患病率高达1%至2%。
  • 声明涵盖由各种形式心肌病引起的射血分数降低和轻度降低的心力衰竭。

临床怎么用

  • 应推进标准化疾病定义和诊断阈值,改进诊断标准以辅助疾病识别,并使用有效筛查工具。
  • 未来方向包括优先将妊娠及产后个体纳入心力衰竭研究,实施促进早期疾病检测的干预措施。

局限性

  • 妊娠期及产后心力衰竭或左室收缩功能不全的真实发病率与患病率仍属未知。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Heart failure in the perinatal period remains ambiguous in definition and management despite its recognition as a unique disease state. The true incidence and prevalence of heart failure or left ventricular systolic dysfunction during pregnancy and the postpartum period are unknown, although a prevalence as high as 1% to 2% has been reported in the general adult US population. Assessment of heart failure can be challenging in the pregnant or postpartum state, during which symptoms affecting physical function (eg, dyspnea, exercise intolerance, fatigue, and lower-extremity edema) are prevalent because of physiological changes. Delays in the recognition and diagnosis of heart failure during the perinatal period contribute to adverse maternal outcomes, highlighting the need for evidence-based definitions and thresholds, improved diagnostic criteria to aid disease recognition, and effective screening tools. This scientific statement focuses on heart failure with reduced and mildly reduced ejection fraction in the context of pregnancy and the postpartum period, caused by various forms of cardiomyopathy. It addresses challenges related to recognizing heart failure in obstetric patients, outlines established treatment standards, and underscores potential areas for research. To improve the management of preexisting and de novo heart failure in obstetric patients, standardization of disease definitions, specific therapeutic options, implementation of effective screening tools, and interventions to improve maternal health equity are imperative. Future directions include prioritizing the inclusion of pregnant and postpartum individuals in heart failure studies, implementing interventions that facilitate early disease detection, and ensuring the timely initiation of appropriate therapies with the goal of reducing adverse outcomes associated with perinatal heart failure.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Adedinsewo, Brown, Hameed, et al. Heart Failure Occurring in the Perinatal Period: A Scientific Statement From the American Heart Association. Circulation. 2026. PMID: 42339539. doi:10.1161/CIR.0000000000001450

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。